Back to Search Start Over

Return to Work and Associated Costs after Treatment for Dupuytren's Disease.

Authors :
Blake SN
Poelstra R
Andrinopoulou ER
Obdeijn MC
van de Oest MJW
Feitz R
Burdorf A
Selles RW
Source :
Plastic and reconstructive surgery [Plast Reconstr Surg] 2021 Sep 01; Vol. 148 (3), pp. 580-590.
Publication Year :
2021

Abstract

Background: Return to work is potentially an important factor in assessing the success of treatment. However, little is known about the return to work after treatment for Dupuytren's contracture. Therefore, the primary aim of this study was to assess return to work after limited fasciectomy and percutaneous needle fasciotomy.<br />Methods: Patients who underwent either a limited fasciectomy or percutaneous needle fasciotomy were invited to complete a return-to-work questionnaire at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Median time to return to work was assessed using inverted Kaplan-Meier curves, and hazard ratios were calculated with Cox regression models. Finally, a cost analysis was carried out using the human capital method to determine indirect costs associated with loss of productivity.<br />Results: The authors included 2698 patients in the study, of which 53 percent were employed at intake and included in the follow-up. After 1 year of follow-up, 90 percent of the patients had returned to work. Median time to return to work was 2 weeks after limited fasciectomy and within days after percutaneous needle fasciotomy. Furthermore, physically strenuous work, female sex, and higher age were associated with a longer time to return to work. Lost productivity per patient was estimated at €2614.43.<br />Conclusions: The majority of patients returned to work after treatment for Dupuytren's disease. Return to work is much faster after percutaneous needle fasciotomy compared to limited fasciectomy. These findings can be used for more evidence-based preoperative counseling with patients with Dupuytren's disease.<br />Competing Interests: Disclosure:The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The authors received no financial support for research, authorship, and/or publication of this article.<br /> (Copyright © 2021 by the American Society of Plastic Surgeons.)

Details

Language :
English
ISSN :
1529-4242
Volume :
148
Issue :
3
Database :
MEDLINE
Journal :
Plastic and reconstructive surgery
Publication Type :
Academic Journal
Accession number :
34292887
Full Text :
https://doi.org/10.1097/PRS.0000000000008224